{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:13:29Z","timestamp":1692670409217},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2\u2009\u00b1\u200916.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% <jats:italic toggle=\"yes\">vs.<\/jats:italic> 88.0%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.036).<\/jats:p>","DOI":"10.1097\/mat.0000000000000375","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T12:18:40Z","timestamp":1458908320000},"page":"498-500","source":"Crossref","is-referenced-by-count":2,"title":["Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis"],"prefix":"10.1097","volume":"62","author":[{"given":"Linnea","family":"Xuereb","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline H.","family":"Go","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babbaljeet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvy","family":"Akrawe","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Borgi","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Paone","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow LVAD.","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary LVAD.","volume":"54","author":"Pagani","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230821","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAT.0000000000000191","article-title":"Lessons learned from 150 continuous flow LVADs: A single institutional seven-year experience.","volume":"61","author":"Tsiouris","year":"2015","journal-title":"ASAIO J"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1532\/HSF98.2014386","article-title":"Should LVADs be implanted in patients over seventy years of age and older.","volume":"17","author":"Morgan","year":"2014","journal-title":"Heart Surg Forum"},{"key":"R5-20230821","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jocs.12048","article-title":"Is resternotomy a risk for continuous LVAD outcomes.","volume":"28","author":"Tsiouris","year":"2013","journal-title":"J Card Surg"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MAT.0000000000000048","article-title":"Sex-specific outcomes in patients receiving continuous-flow LVADs as a bridge to transplantation or destination therapy.","volume":"60","author":"Tsiouris","year":"2014","journal-title":"ASAIO J"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.healun.2012.11.017","article-title":"Continuous-flow LVAD as a bridge to transplantation or destination therapy: Racial disparities in outcomes.","volume":"32","author":"Tsiouris","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R8-20230821","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.healun.2013.09.009","article-title":"Impact of concomitant cardiac procedures performed during implantation of long-term LVADs.","volume":"32","author":"Morgan","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lt.20906","article-title":"MELD-XI: A rational approach to \u201csickest first\u201d liver transplantation in cirrhotic patients requiring anticoagulant therapy.","volume":"13","author":"Heuman","year":"2007","journal-title":"Liver Transpl"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jocs.12318","article-title":"HeartMate II LVAD implantation in patients with advanced hepatic dysfunction.","volume":"29","author":"Demirozu","year":"2014","journal-title":"J Card Surg"},{"key":"R11-20230821","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10047-015-0853-x","article-title":"Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.","volume":"19","author":"Yost","year":"2016","journal-title":"J Artif Organs"},{"key":"R12-20230821","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.athoracsur.2012.02.008","article-title":"Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.","volume":"93","author":"Bonde","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R13-20230821","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","article-title":"Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.","volume":"31","author":"Yang","year":"2012","journal-title":"J Heart Lung Transplant"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002480-201607000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T01:31:58Z","timestamp":1692667918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201607000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000000375","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}